RedHill Biopharma Ltd receives two Notices of Allowance from the US Patent and Trademark Office covering opaganib and RHB-107 as methods for the treatment of COVID-19
Opaganib and RHB-107 are both novel COVID-19 therapeutic candidates, in oral pill form, with dual mechanism of action effects. Both are host-targeted...